Article

PharmTech Sponsored eBooks

May 1, 2020

PharmTech Sponsored eBooks

PharmTech Sponsored eBooks-05-01-2020

VolumeSponsored eBook

Issue 6

Pages: 20-23

Trends and Formulation Strategies for Topical Drugs

Author(s):

Drug developers are increasingly using topical dosage forms for numerous reasons, but several factors must be considered to optimize the API's functionality including excipient selection. Trends and Formulation Strategies for Topical Drugs explores this topic and other areas of interest to developers.

Read this article

Articles in this issue

Screen Shot 2020-06-01 at 9.32.11 AM.png

Complications in Process Simulation Execution

Screen Shot 2020-06-01 at 10.46.20 AM.png

Minimizing Contamination During BioPharm R&D

Trends and Formulation Strategies for Topical Drugs

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Content

August 1st 2025

The Roadmap to Asset Performance Management in Life Science

August 1st 2025

Unlock the Future of Enterprise Asset Management with Agentic AI

August 1st 2025

From Maintenance to Compliance: A Guide to CMMS/EAM Readiness

August 1st 2025

Executive Summary: End-To-End Regulatory CDMO Solutions: Development, Manufacturing, and Approval

The road to market access is long and complex. Choosing a CDMO with experienced staff can prove vital to success. In this executive summary, Praveenkumar Devakadaksham and Dr. Roché Marcel Walliser explain all the ways they help make the journey from pharmaceutical development to commercial distribution as smooth as possible. Learn more about:

August 1st 2025

Executive Summary: Keys to Supplying Decentralized Trials: The Value of Direct-to-Patient Solutions and the Pharmacy-Led Model

August 1st 2025

Innovations in Pregastric Absorption Drug Delivery & Orally Disintegrating Tablets

Related Content

August 1st 2025

The Roadmap to Asset Performance Management in Life Science

August 1st 2025

Unlock the Future of Enterprise Asset Management with Agentic AI

August 1st 2025

From Maintenance to Compliance: A Guide to CMMS/EAM Readiness

August 1st 2025

Executive Summary: End-To-End Regulatory CDMO Solutions: Development, Manufacturing, and Approval

The road to market access is long and complex. Choosing a CDMO with experienced staff can prove vital to success. In this executive summary, Praveenkumar Devakadaksham and Dr. Roché Marcel Walliser explain all the ways they help make the journey from pharmaceutical development to commercial distribution as smooth as possible. Learn more about:

August 1st 2025

Executive Summary: Keys to Supplying Decentralized Trials: The Value of Direct-to-Patient Solutions and the Pharmacy-Led Model

August 1st 2025

Innovations in Pregastric Absorption Drug Delivery & Orally Disintegrating Tablets

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.